Delia Marie Gilbertsen, PA-C

Delia Gilbertsen practices at Coddington Medical Family Practice in Lincoln, Nebraska.

Delia Gilbertsen's NPI, 1447712393, was assigned on April 1, 2019. Delia Gilbertsen holds Nebraska license 2344.

Delia Gilbertsen's primary practice is Coddington Medical Family Practice, at 1336 W A St Suite A Suite A, Lincoln, NE 68522-1231. The practice phone is (402) 438-0101.

Delia Gilbertsen's primary practice is Coddington Medical Family Practice in Lincoln, Nebraska. Delia Gilbertsen is also affiliated with Bryan Medical Center. The medical group on file is Capital Medical Clinic. Dmand AI also links Delia Gilbertsen to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Delia Gilbertsen practices, 3 sites in all. Vendor and product names are available with a free account.

General practice is Delia Gilbertsen's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Delia Gilbertsen is licensed in Nebraska.

CMS data shows 134 Medicare services from Delia Gilbertsen across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $5,715 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Delia Gilbertsen in 2024. The largest group is 65 to 74, with 45 patients. 63% of them have high blood pressure, and 51% have high cholesterol. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Delia Gilbertsen's median patient age at 52, with 72% women.

In 2024, Delia Gilbertsen wrote 802 Medicare Part D claims for 225 patients. 92% of them were for generic drugs. CMS names the drug for 491 of them, across 25 drugs with 11 or more claims each, at $4,203 in total drug cost. In 2023, CMS named 378 claims across 22 drugs.

Delia Gilbertsen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 51 general payments to Delia Gilbertsen from 17 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $280.